Delays to Low-Risk Thyroid Cancer Treatment During COVID-19-Refocusing From What Has Been Lost to What May Be Learned and Gained

被引:15
|
作者
Nickel, Brooke [1 ,2 ]
Glover, Anthony [3 ]
Miller, Julie A. [4 ,5 ,6 ]
机构
[1] Univ Sydney, Fac Med & Hlth, Sydney Sch Publ Hlth, Wiser Healthcare, Sydney, NSW 2006, Australia
[2] Univ Sydney, Fac Med & Hlth, Sydney Sch Publ Hlth, Sydney Hlth Literacy Lab, Sydney, NSW, Australia
[3] Univ Sydney, Fac Med & Hlth, Royal North Shore Hosp, Endocrine Surg Unit,Sydney Med Sch, Sydney, NSW, Australia
[4] Univ New SouthW, Garvan Inst Med Res, St Vincents Clin Sch, Fac Med,Kinghorn Canc Ctr,Endocrine Canc Program, Sydney, NSW, Australia
[5] Royal Melbourne Hosp, Endocrine Surg Unit, Melbourne, Vic, Australia
[6] Univ Melbourne, Dept Surg, Melbourne, Vic, Australia
关键词
MANAGEMENT;
D O I
10.1001/jamaoto.2020.3878
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
引用
收藏
页码:5 / 6
页数:2
相关论文
共 1 条
  • [1] Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic
    Palladino, Raffaele
    Migliatico, Ilaria
    Sgariglia, Roberta
    Nacchio, Mariantonia
    Iaccarino, Antonino
    Malapelle, Umberto
    Vigliar, Elena
    Salvatore, Domenico
    Troncone, Giancarlo
    Bellevicine, Claudio
    ENDOCRINE, 2021, 71 (01) : 20 - 25